[{"Assets_0_Q1_USD":324550.0,"CommonStockSharesOutstanding_0_Q1_shares":2875000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-450.0,"NetIncomeLoss_1_Q1_USD":-450.0,"StockholdersEquity_0_Q1_USD":24102.0,"Ticker":"IMVT","CIK":"1764013","name":"HEALTH SCIENCES ACQUISITIONS CORP","OfficialName":"Immunovant Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"407422400.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190612"}]